For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

Robert F. Kennedy Jr. dismissed all members of the CDC’s Advisory Committee on Immunization Practices, which recommends which ...

The S&P 500 added 0.9% on Monday, June 16, as investors absorbed the possibility of cooling geopolitical tensions and looked ...

Kraft Heinz announced on Tuesday that it would be removing artificial food dyes from its products within the next two ...

A federal judge in Massachusetts ruled on Monday that directives from the Trump administration that led to the cancellations ...